Pricing tool · Prices verified through August 2026

What Tirzepatide Costs a Month, Across 254 Providers

254 providers publish a monthly Tirzepatide rate, 393 rates between them. Half of the 311 compounded rates fall between $179 and $299. A further 220 published figures are not monthly rates at all and are counted separately rather than averaged in.

What Tirzepatide costs a month, by what you are actually buying

254 providers publish a monthly Tirzepatide rate and 393 rates between them. The table below is those rates, split by form, with the quartiles inside each. Nothing is averaged across the rows of two different forms: a compounded vial and an FDA-approved pen are different products, and one median over both would describe a market nobody buys in.

The full range is the least useful part of it. The cheapest and dearest figure in any of these groups is one outlier against another; the middle half is where a reader comparing two quotes is actually standing.

Monthly Tirzepatide rates by delivery form: the number of rates, the cheapest, the middle half, the median and the dearest in each.
What you are buyingRatesCheapestMiddle halfMedianDearest
Tirzepatide, compounded232 providers311$45$179–$299the middle half of 311 compounded rates$239a month, compounded$649
Tirzepatide, brand-name41 providers53$299$299–$1,399the middle half of 53 brand-name rates$650a month, brand-name$1,899
Tirzepatide, compounded oral27 providers29$109$199–$299the middle half of 29 compounded oral rates$249a month, compounded oral$399

The brand-name figure is two markets wearing one number

The median compounded Tirzepatide rate is $239 and the median brand-name rate is $650. The gap between those two medians is the one most comparisons stop at, and it is the less interesting half of the finding.

The middle half of the 311 compounded rates runs $179 to $299 — a band of $120. The middle half of the 53 brand-name rates runs $299 to $1,399, a band of $1,100. A brand price is not one price with some variation around it; it is a covered price and a cash price sitting in the same column, and which one a reader is quoted depends on a coverage decision made before the figure means anything.

That is why this site records an insurance condition on a price as a field rather than as a caveat in prose, and why the brand-name column on any board here is read with the condition attached.

The 220 Tirzepatide figures this page could not use

220 published Tirzepatide figures, from 116 providers, are not monthly rates. They are per-day figures, per-fill figures, and totals for a plan of three, six or twelve months that the provider never divides. Across the whole roster, per-fill and other nonmonthly figures are excluded from monthly comparisons.

What that looks like on a page: TRYM Health publishes $4.20 for multi-dose vials, GLP-1 + GIP, Peptivo publishes $7.06 for Tirzepatide/Glycine/B12 injection, 90-day titration and maintenance bundles, and Ivologist publishes $58 for Tirzepatide Microdosing starter program. Each of those is a real published figure; none of them is a month.

None of them is included in any quartile above. Dividing a 90-day bundle by three to make it comparable would be this site inventing a monthly rate its source never published — and a figure invented that way is indistinguishable, on the page, from one a provider actually charges. They are counted here instead, because a market where a third of the published figures cannot be compared by the month is itself the answer to how easy these prices are to compare.